Short Communication - (2025) Volume 16, Issue 5
Received: 01-Oct-2025, Manuscript No. jtse-26-184783;
Editor assigned: 03-Oct-2025, Pre QC No. P-184783;
Reviewed: 17-Oct-2025, QC No. Q-184783;
Revised: 22-Oct-2025, Manuscript No. R-184783;
Published:
29-Oct-2025
, DOI: 10.37421/2157-7552.2025.16.461
Citation: Zahra, Fatima. ”Advancements in Bone and Cartilage Tissue Engineering.” J Tissue Sci Eng 16 (2025):461.
Copyright: © 2025 Zahra F. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
The field of tissue engineering has made significant strides in addressing the complex challenges of bone and cartilage repair, with a particular emphasis on developing advanced strategies for creating functional tissue substitutes. Biomaterial selection plays a pivotal role in this process, influencing cellular behavior, tissue integration, and overall therapeutic efficacy in regenerative medicine. Innovations in scaffold fabrication, cell sourcing, and bioreactor design are continuously pushing the boundaries of what is achievable in creating functional tissue replacements for various defects and diseases [1].
Cartilage, characterized by its avascular nature and limited intrinsic repair capabilities, presents unique hurdles in tissue engineering endeavors. Overcoming these limitations requires meticulous consideration of scaffold properties, cell types, and the application of appropriate mechanical stimuli to guide chondrogenesis. Research is actively exploring novel materials and therapeutic approaches to restore the structure and function of damaged cartilage [2].
One of the most promising advancements in creating complex tissue constructs, particularly for osteochondral defects, is the application of 3D bioprinting. This technology enables the precise deposition of multiple materials, including cells and biomolecules, to fabricate intricate scaffolds that mimic the layered architecture of native tissues, thereby facilitating simultaneous bone and cartilage regeneration [3].
Beyond scaffold-based approaches, the therapeutic potential of extracellular vesicles (EVs), especially those derived from mesenchymal stem cells (MSCs), is emerging as a significant area of research. These cell-free therapeutic agents carry bioactive molecules that can modulate inflammatory responses and promote tissue regeneration, offering a promising alternative or adjunct to cell-based therapies with reduced immunogenic concerns [4].
Biomechanics plays a crucial role in the development of functional cartilage tissue. Mechanical stimulation, such as compression and fluid flow, has been shown to profoundly influence chondrocyte behavior, matrix synthesis, and overall tissue development. The design of bioreactors that can replicate physiological loading conditions is therefore essential for engineering cartilage that can withstand mechanical stresses in vivo [5].
The use of decellularized extracellular matrix (dECM) derived from native bone and cartilage tissues represents a biomimetic approach to scaffold design. dECM scaffolds preserve the intricate architecture and biochemical cues of the native microenvironment, providing a conducive substrate for cell adhesion, proliferation, and differentiation, thereby promoting osteogenesis and chondrogenesis [6].
Induced pluripotent stem cells (iPSCs) are being investigated for their potential in bone and cartilage regeneration due to their ability to differentiate into various skeletal cell lineages. While challenges related to differentiation efficiency and safety persist, iPSCs offer a renewable and potentially patient-specific cell source for regenerative therapies, especially when combined with appropriate biomaterial scaffolds [7].
Synthetic polymers and their composites constitute a significant class of materials used in bone tissue engineering. Materials like PLGA, PCL, and HA composites are evaluated for their ability to support osteogenesis, with scaffold design, mechanical properties, and degradation rates being critical considerations. Surface modifications and the incorporation of bioactive agents further enhance their regenerative capacity [8].
Modulating the local immune response is becoming increasingly recognized as a critical factor in achieving successful cartilage regeneration. Inflammation can impede repair processes; therefore, strategies employing immunomodulatory agents and cells aim to create a pro-regenerative microenvironment that favors chondrogenesis and matrix production over fibrotic responses [9].
Vascularization remains a significant challenge for the successful regeneration of larger bone and cartilage tissue constructs. The development of functional vascular networks is essential for delivering oxygen and nutrients, supporting cell survival, and promoting integration. Various approaches, including growth factors, endothelial cells, and advanced fabrication techniques, are being explored to achieve adequate vascularization [10].
This article explores advanced strategies in bone and cartilage tissue engineering, focusing on biomaterial selection, cell sourcing, and bioreactor design. It highlights innovations in creating functional tissue substitutes for treating defects and diseases. Key insights include the use of decellularized extracellular matrices and advanced 3D printing techniques for fabricating scaffolds that mimic native tissue architecture and mechanical properties. The integration of growth factors and advanced cell culture methods are also discussed as crucial for enhancing cellular differentiation and tissue regeneration [1].
The review details the current landscape of cartilage tissue engineering, emphasizing the challenges posed by the avascular nature of cartilage and its limited self-repair capacity. It discusses various scaffold materials, including natural polymers and synthetic composites, designed to provide structural support and guide chondrogenesis. The role of mesenchymal stem cells (MSCs) and their paracrine signaling in promoting cartilage repair is a significant focus. Furthermore, advancements in bioreactor technologies that simulate the mechanical loading experienced by articular cartilage are presented as essential for developing functional engineered tissues [2].
This paper delves into the application of 3D bioprinting for creating complex osteochondral constructs. It examines the design of multi-material scaffolds that can support both bone and cartilage regeneration simultaneously. The article discusses the choice of bioinks, including hydrogels and cell-laden materials, and their ability to maintain cell viability and promote differentiation into respective lineages. Techniques for printing intricate structures that mimic the gradient properties of the osteochondral interface are also a key theme, offering promising avenues for treating large osteochondral defects [3].
The research highlights the potential of extracellular vesicles (EVs), particularly exosomes, derived from mesenchymal stem cells (MSCs) in enhancing bone and cartilage repair. These EVs carry bioactive molecules that can modulate inflammatory responses, promote cell proliferation, and induce differentiation towards osteogenic and chondrogenic lineages. The article discusses strategies for isolating and characterizing MSC-derived EVs and their application in scaffold-based therapies, offering a cell-free approach to tissue regeneration with reduced immunogenicity [4].
This review examines the role of biomechanical stimulation in cartilage tissue engineering. It emphasizes how mechanical cues, such as compression and fluid flow, can influence chondrocyte behavior, matrix synthesis, and tissue development. The article discusses the design of bioreactors capable of applying physiological loading conditions to engineered cartilage constructs. Understanding and replicating these mechanical signals are presented as critical for achieving functional cartilage tissue that can withstand physiological stresses, leading to improved integration and long-term outcomes [5].
The study investigates the use of decellularized extracellular matrix (dECM) derived from bone and cartilage for tissue engineering applications. It details the process of dECM preparation and its advantages, including preserving the native tissue architecture and biochemical composition, which are crucial for cell adhesion, proliferation, and differentiation. The authors explore how dECM scaffolds can be functionalized with growth factors and cells to promote osteogenesis and chondrogenesis, offering a promising biomimetic approach for skeletal tissue repair [6].
This article reviews the therapeutic potential of induced pluripotent stem cells (iPSCs) for bone and cartilage regeneration. It discusses the ability of iPSCs to differentiate into various skeletal cell types, including osteoblasts and chondrocytes, offering a renewable and patient-specific cell source. The authors highlight challenges related to iPSC differentiation protocols, genomic stability, and the risk of teratoma formation, while also presenting strategies to overcome these hurdles for clinical translation. The use of iPSCs in combination with biomaterial scaffolds is also explored [7].
This paper focuses on the use of synthetic polymers and their composites in bone tissue engineering. It evaluates various synthetic materials, such as poly(lactic-co-glycolic acid) (PLGA), polycaprolactone (PCL), and hydroxyapatite (HA) composites, for their ability to support osteogenesis. The authors discuss scaffold design, porosity, mechanical strength, and degradation rates as critical factors influencing bone regeneration. Surface modifications and the incorporation of bioactive agents to enhance cell attachment and osteogenic differentiation are also detailed [8].
This work investigates the application of immunomodulatory strategies in cartilage tissue engineering to promote a pro-regenerative environment. The authors discuss how inflammation can hinder cartilage repair and explore the use of anti-inflammatory agents and immune cells, such as regulatory T cells, to modulate the local immune response. The goal is to create a microenvironment that favors chondrogenesis and the production of healthy cartilage matrix, rather than fibrosis or scar tissue formation, leading to improved functional outcomes [9].
This article reviews the progress and challenges in vascularization strategies for engineered bone and cartilage tissues. It addresses the critical need for vascular networks to deliver nutrients and oxygen to larger tissue constructs, which is essential for cell survival and tissue integration. The authors discuss various approaches, including the use of pro-angiogenic factors, endothelial cells, and pre-vascularized scaffolds, as well as advancements in 3D bioprinting and microfluidic technologies to create functional vascular networks within engineered tissues [10].
This collection of research highlights advancements in bone and cartilage tissue engineering. Key strategies include the use of biomaterials, such as decellularized extracellular matrices and synthetic polymers, along with 3D bioprinting for creating complex scaffolds. Mesenchymal stem cells (MSCs) and their derived extracellular vesicles (EVs) are explored for their regenerative potential, offering cell-based and cell-free therapeutic options. Biomechanical stimulation and immunomodulatory approaches are crucial for optimizing cartilage tissue development and promoting a pro-regenerative environment. Induced pluripotent stem cells (iPSCs) present a renewable cell source, while vascularization remains a critical challenge for larger tissue constructs. Overall, the research focuses on developing functional tissue substitutes by integrating material science, cell biology, and advanced engineering techniques to address skeletal tissue defects.
None
None
Journal of Tissue Science and Engineering received 807 citations as per Google Scholar report
